Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06545955 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Ferring Pharmaceuticals |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06545955 is currently recruiting participants. This clinical trial study for bladder cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Ferring Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06545955 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06545955 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.